Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials.

作者
Ya-Ru Zheng,Zhiyun Chen,Lifang Ye,Lihong Wang
出处
期刊:PubMed Central - Europe PMC [European Bioinformatics Institute]
卷期号:12 (5): 507-14 被引量:13
标识
DOI:10.11909/j.issn.1671-5411.2015.05.012
摘要

BACKGROUND: Atrial fibrillation (AF) is an independent risk factor for ischemic stroke and is associated with increased risk of death. Randomized studies suggest improved quality of life for patients with AF after successful catheter ablation compared to antiarrhythmic drug therapy. The value of ablation in long-term risk of ischemic stroke, however, has not been assessed. We conducted a meta-analysis to determine whether AF ablation reduces the long-term risk of stroke compared to antiarrhythmic drug therapy in randomized controlled trials. METHODS & RESULTS: PubMed and the Cochrane Central Register were searched for randomized trials from January 1990 to December 2014 comparing AF catheter ablation to drug therapy. The results are reported as risk differences (RDs) and 95% CI. Thirteen trials were analyzed with 1097 patients treated by catheter ablation and 855 patients received antiarrhythmic drug therapy. Overall, seven patients (0.64%) in the catheter ablation group had ischemic stroke or transient ischemic attacks vs. two patients (0.23%) in the drug therapy group. No difference was shown in the rate of stroke or transient ischemic attack between ablation and drug therapy (RD: 0.003, 95% CI: -0.006 to 0.012, P = 0.470), and no evidence of heterogeneity was observed (I (2) = 0, P = 0.981). No potential publication bias was found. There was also no difference in mortality between the two groups (RD: -0.004, 95% CI: -0.014 to 0.006, P = 0.472). CONCLUSIONS: This meta-analysis of randomized controlled trials showed similar rates of ischemic stroke or transient ischemic attack and death in AF patients undergoing catheter ablation compared to drug therapy. A larger prospective randomized trial to confirm this finding is warranted.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
铁锤牛马版的应助被Heimdall采纳,获得150
刚刚
yxguangdoc完成签到,获得积分10
刚刚
彭于彦祖的应助被Gallavich采纳,获得50
刚刚
黄豆完成签到,获得积分10
2秒前
明良韵完成签到,获得积分10
2秒前
尘林完成签到,获得积分10
2秒前
对白完成签到,获得积分10
3秒前
嘻嘻哈哈的应助被wodetaiyangLLL采纳,获得10
3秒前
shi完成签到,获得积分10
3秒前
科研助手完成签到 ,获得积分10
3秒前
李相赫完成签到,获得积分10
3秒前
4秒前
小陀螺完成签到,获得积分10
4秒前
刘德新发布了新的文献求助10
4秒前
田様的应助被拓跋灭龙采纳,获得10
5秒前
whhhhhh完成签到 ,获得积分20
5秒前
马也完成签到,获得积分10
5秒前
5秒前
红烧狮子没有头完成签到,获得积分10
5秒前
Lemon完成签到 ,获得积分10
5秒前
科研通AI6.3的应助被刘同学采纳,获得10
5秒前
无语完成签到,获得积分10
5秒前
无忧sxt完成签到 ,获得积分10
5秒前
彭于晏的应助被xxr采纳,获得10
5秒前
mxm完成签到,获得积分10
5秒前
kiana完成签到,获得积分10
5秒前
李爱国的应助被Bai采纳,获得10
5秒前
笨笨是研究生的应助被AXX041795采纳,获得10
6秒前
水煮电吹风的应助被DEVIL采纳,获得10
6秒前
曹孟德完成签到,获得积分10
6秒前
orixero的应助被害羞大碗采纳,获得10
6秒前
852的应助被kobe采纳,获得10
6秒前
尼古拉斯完成签到,获得积分10
6秒前
李爱国的应助被稚未采纳,获得10
6秒前
6秒前
jian完成签到,获得积分10
7秒前
林洁佳完成签到,获得积分10
7秒前
wy2完成签到,获得积分10
7秒前
chenc完成签到,获得积分10
7秒前
zizhu完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180407
求助须知:如何正确求助?哪些是违规求助? 9570403
关于积分的说明 21811831
捐赠科研通 7776452
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557499
邀请新用户注册赠送积分活动 2479105